PNC Financial Services Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$358 Buy
27
+22
+440% +$491 ﹤0.01% 5040
2026
Q1
$133 Buy
5
+3
+150% +$377 ﹤0.01% 5079
2025
Q4
$617 Sell
2
-2
-50% -$457 ﹤0.01% 4793
2025
Q3
$760 Buy
+4
New +$705 ﹤0.01% 4729
2022
Q4
– Hold
0
– – – 4802
2022
Q3
– Hold
0
– – – 4512
2022
Q1
– Sell
-3
Closed -$2K – 4593
2021
Q4
$2K Sell
3
-2
-40% -$1.9K ﹤0.01% 4159
2021
Q3
$6K Buy
+5
New +$3.68K ﹤0.01% 3881

Other funds holding GOSS

PNC Financial Services Group's GOSS Position: Q2 2026 in Review

PNC Financial Services Group increased its Gossamer Bio (GOSS) stake by 440% in Q2 2026, buying an estimated $491 and bringing the position to 27 shares worth $358. The position accounts for ﹤0.01% of the portfolio, ranked #5040.

PNC Financial Services Group first reported a position in GOSS in Q3 2021 and has held it in 6 quarters since. The position peaked at $6K in Q3 2021. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • PNC Financial Services Group held 27 shares of Gossamer Bio worth $358 as of Q2 2026.
  • PNC Financial Services Group bought 22 Gossamer Bio shares in Q2 2026, an estimated $491.
  • Gossamer Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5040 holding.
  • PNC Financial Services Group first reported a position in Gossamer Bio in Q3 2021 and has held it in 6 quarters since.
  • PNC Financial Services Group's Gossamer Bio position peaked at $6K in Q3 2021.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.